维普中文期刊产品整合服务
38篇 您的检索式:作者名="Sadaie"
    题名 作者 年代 出处 被引量
1Biogenic Accumulations of Uranium in Recent Seas显示文摘The objective of this study is to determine the geochemical role of molluscs in the distribution of uranium in the marine ecosystem. Biogeochemical studies are carried out on recent mollusc shells from the Caspian Sea, Sea of Japan, Sea of Marmara, Aegean Sea, Black Sea, Mediterranean Sea, Baltic Sea, and Indian Ocean, which differ from each other in terms of physical, chemical, geographic, and geochemical characteristics. In this study, nine Gastropoda and fifty-four Pelecypoda shells of different species are analyzed to document variations of uranium in seasonal layers, which were formed by the seasonal carbonate-organic phase of molluscs during their entire lives. Shell used in this study principally comprises three layers: upper (outer) prismatic, middle prismatic, and inner (mother-of-pearl) layers. In addition, when possible, the head, the middle, and the lower parts of the shells are used for analyses separately. Also, the biological accumulation rate values for each different mollusc species relative to the average uranium value in seawater are calculated. The BAR values of U in mollusc shells range between 11 and 216. Uranium concentrations in recent mollusc shells vary between 0.034 ppm and 0.65 ppm. Organic carbon values vary between 1100 and 9700 ppm in various mollusc species. The uranium and Corg concentrations in living mollusc shells are positively correlated. Both the uranium and Corg contents in mollusc shells are preferably dependent on the taxonomic characteristics of organisms. It has been observed that the uranium concentrations in the mineral-organic phase of molluscs are in good agreement with those of surrounding sediments. Therefore, the changes in the uranium concentrations in shell and sediment types are derived from the uranium concentrations in water.Saday Azado■lu ALlYEV Ali SARI 2003Acta Geologica Sinica(English Edition)2003,77,3:2
2Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CN8 disorders显示文摘Maiykh AG Sadaie MR 2010Drugs2010,70,5:1
3Piracetam and Piracetam - Like Drugs : from basic science to novel clinical applications to CNS disorders 显示文摘Malykh AG Sadaie DR 2010Drugs2010,70,3:1
4Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disor- ders显示文摘Malykh AG Sadaie MR 2010Drugs2010,70,3:1
5A novel approach to develop anti-HIV drugs:adapting non-nucleoside anticancer chemotherapeutics显示文摘Sadaie MR Mayner R Doniger J 2004Antiviral Res2004,61,:1
6A novel approach to develop anti-HIV drugs: adapting nonnucleoside anticancer chemotherapeutics显示文摘SADAIE M R MAYNER R DONIGER J 2004Antiviral Res2004,61,1:1
7Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs 显示文摘KASHANCHI F SADAIE M R BRADY J N 1997Virology1997,227,2:1
8Piracetam and piracetam-like drugs:from basic science to novel clinical applications to CNS disorders显示文摘Malykh AG Sadaie MR 2010Drugs2010,70,3:1
9Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders 显示文摘Malykh AG Sadaie MR 2010Drugs2010,70,3:1
10Phosphorylation by aurora kinase A induces mda2-mediated destabilization and inhibition of p53 显示文摘Katayama H Sadai K Kawai H 2004Nat Genet2004,36,1:1
11Piracetam and piracetam-like drugs:from basic science to novel clinical applications to CNS disorders显示文摘Malykh AG Sadaie MR 0,,03:1
12Inhibition of HIV-1 transcription and virus replication using soluble Tat peptide analogs 显示文摘Kashanchi F Sadaie MR Brady JN 1997Virology1997,227,:1
13Piracetam and piracetam-like drugs : from basicscience to novel clinical applications to CNS disorders显示文摘Malykh AG Sadaie MR 2010Drugs2010,70,3:1
14Piracetam and piracetam-like drugs:from basic science to novel clinical applications to CNS disorders显示文摘Malykh AG Sadaie MR 2010Drugs2010,70,:1
15A novel approach to develop anti-HIV-I drugs adapting non-nucleoside anticancer chem otherapeutics显示文摘Sadaie M R Mayner R Doniger J 0,,01:1
169-nitrocamptothecin selec tively inhibits human immunodeficiency virus type Ⅰ replication in freshly infected parental but not 9-nitrocamptothecin-resistant U937 monocytoid cells显示文摘Sadaie MR Doniger J Hung CL 1999AIDS Res Hum Retroviruses1999,15,3:1
17Piracetam and piracetam-like drugs~ from basicscience to novel clinical applications to CNS disorders 显示文摘Malykh AG Sadaie MR 2010Drugs2010,70,3:1
18Piracetam and piracetam-like drugs:from basic science to novel clinical applications to CNS disorders显示文摘Malykh AG Sadaie MR 2010Drugs2010,70,3:1
19Cellular senescence and its effector programs 显示文摘Salama R Sadaie M Hoare M 2014GenesDev2014,28,2:1
20Piracetam and piracelam-like drugs:form basic science to novel clinical applications to CNS disorders显示文摘Malykh AG Sadaie MR 0,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费